What is Accendra Health Inc's earnings per share (EPS)?

Accendra Health Inc (ACH) reported diluted earnings per share of $-14.31 for fiscal year 2025. This represents a -202.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Accendra Health Inc Financials

ACH

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Accendra Health Inc (ACH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ACH FY2025 2026-04-22

A leaner revenue mix lifted reported margins, but cash burn and balance-sheet strain now govern how the business functions.

Since FY2023, gross margins stayed unusually high—83.3% in FY2023 and 82.8% in FY2024—yet that margin shape did not turn into durable cash. By FY2025, operating cash flow had swung from $740.7M to -$101.8M, showing that overhead and reinvestment were absorbing the benefit of a leaner revenue mix.

FY2025 ended with negative equity of -$461.0M, so creditors are financing more than the full asset base rather than just supplementing shareholder capital. The same strain shows up in liquidity: current assets were $547.9M against current liabilities of $947.1M, which means routine obligations cannot be covered from near-term assets alone.

Inventory dropped from $1.5B in FY2021 to $74.4M in FY2025. Combined with gross margin moving from 15.5% to 46.7%, that points to a business mix reset rather than a temporary sales wobble: much less of each revenue dollar now depends on carrying goods on the balance sheet.

Financial Health Signals

Financial Profile 21/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Accendra Health Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Accendra Health Inc has an operating margin of 1.0%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 20/100, suggesting thin profitability after operating expenses. This is up from -8.1% the prior year.

Growth

Accendra Health Inc's revenue grew a modest 3.1% year-over-year to $2.8B. This slow but positive growth earns a score of 40/100.

Leverage

Accendra Health Inc has a moderate D/E ratio of -3.90. This balance of debt and equity financing earns a leverage score of 39/100.

Liquidity

Accendra Health Inc's current ratio of 0.58 is below the typical benchmark, resulting in a score of 6/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Accendra Health Inc generated -$101.8M in operating cash flow, capex of $191.0M consumed most of it, leaving -$292.7M in free cash flow. This results in a low score of 23/100, reflecting heavy capital investment rather than weak cash generation.

Altman Z-Score Distress

0.40

Accendra Health Inc scores 0.40, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Weak

3/9

Accendra Health Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.09x

For every $1 of reported earnings, Accendra Health Inc generates $0.09 in operating cash flow (-$101.8M OCF vs -$1.1B net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

0.3x

Accendra Health Inc earns $0.3 in operating income for every $1 of interest expense ($27.5M vs $107.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.8B

YoY+3.1%

5Y CAGR-20.1%

10Y CAGR-11.9%

Accendra Health Inc generated $2.8B in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.

EBITDA

$242.0M

YoY+763.9%

5Y CAGR-4.0%

10Y CAGR-1.0%

Accendra Health Inc's EBITDA was $242.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 763.9% from the prior year.

Net Income

-$1.1B

YoY-203.5%

Accendra Health Inc reported -$1.1B in net income in fiscal year 2025. This represents a decrease of 203.5% from the prior year.

EPS (Diluted)

$-14.31

YoY-202.5%

Accendra Health Inc earned $-14.31 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 202.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$292.7M

YoY-3230.1%

Accendra Health Inc generated -$292.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 3230.1% from the prior year.

Cash & Debt

$282.0M

YoY+922.7%

5Y CAGR+27.7%

10Y CAGR+5.8%

Accendra Health Inc held $282.0M in cash against $1.8B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

76M

YoY-1.0%

5Y CAGR+0.8%

10Y CAGR+2.0%

Accendra Health Inc had 76M shares outstanding in fiscal year 2025. This represents a decrease of 1.0% from the prior year.

Margins & Returns

Gross Margin

46.7%

YoY-36.1pp

5Y CAGR+31.6pp

10Y CAGR+34.3pp

Accendra Health Inc's gross margin was 46.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 36.1 percentage points from the prior year.

Operating Margin

1.0%

YoY+9.1pp

5Y CAGR-1.4pp

10Y CAGR-1.1pp

Accendra Health Inc's operating margin was 1.0% in fiscal year 2025, reflecting core business profitability. This is up 9.1 percentage points from the prior year.

Net Margin

-39.9%

YoY-26.3pp

5Y CAGR-40.2pp

10Y CAGR-40.9pp

Accendra Health Inc's net profit margin was -39.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 26.3 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

$10.2M

10Y CAGR-6.5%

Accendra Health Inc spent $10.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$191.0M

YoY+12.1%

5Y CAGR+30.5%

10Y CAGR+25.0%

Accendra Health Inc invested $191.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 12.1% from the prior year.

ACH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$2.8B+3.1%	$2.7B+5.0%	$2.6B-74.4%	$10.0B+1.7%	$9.8B+15.4%	$8.5B
Cost of Revenue	$1.5B+5.2%	$1.4B+4.8%	$1.3B-83.6%	$8.1B-1.7%	$8.3B+14.9%	$7.2B
Gross Profit	$1.3B-41.9%	$2.2B+4.4%	$2.1B+16.4%	$1.8B+20.7%	$1.5B+18.1%	$1.3B
R&D Expenses	N/A	$13.0M0.0%	$13.0M+8.3%	$12.0M-0.8%	$12.1M	N/A
SG&A Expenses	$1.1B-1.4%	$1.1B+8.1%	$1.0B-35.6%	$1.6B+44.4%	$1.1B+3.4%	$1.0B
Operating Income	$27.5M+112.6%	-$217.7M-263.4%	$133.2M-6.8%	$142.9M-61.2%	$368.5M+80.5%	$204.1M
Interest Expense	$107.2M-0.4%	$107.6M-7.9%	$116.8M-9.4%	$128.9M+168.0%	$48.1M-42.3%	$83.4M
Income Tax	$729K-96.5%	$20.9M+227.8%	$6.4M+155.3%	-$11.5M-120.8%	$55.2M+152.7%	$21.8M
Net Income	-$1.1B-203.5%	-$362.7M-778.2%	-$41.3M-284.5%	$22.4M-89.9%	$221.6M+641.8%	$29.9M
EPS (Diluted)	$-14.31-202.5%	$-4.73-792.5%	$-0.53-282.8%	$0.29-90.1%	$2.94+525.5%	$0.47

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	$697.3M+2.3%	$681.9M-74.1%	$2.6B	N/A	$686.8M+4.0%	$660.4M-74.7%	$2.6B
Cost of Revenue	N/A	$375.1M+5.0%	$357.3M-83.0%	$2.1B	N/A	$355.1M+3.1%	$344.4M-83.4%	$2.1B
Gross Profit	N/A	$322.2M-0.7%	$324.6M-38.3%	$526.0M	N/A	$559.7M+2.9%	$544.2M+1.6%	$535.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$265.8M-0.8%	$267.9M-42.1%	$462.4M	N/A	$272.3M+0.9%	$269.9M-43.5%	$477.6M
Operating Income	N/A	$26.5M+166.7%	-$39.7M-32124.2%	$124K	N/A	$31.1M+83.7%	$16.9M+74.5%	$9.7M
Interest Expense	N/A	$29.0M+11.6%	$26.0M-23.4%	$34.0M	N/A	$29.0M+13.2%	$25.6M-28.2%	$35.7M
Income Tax	N/A	$2.0M+275.0%	-$1.1M+88.8%	-$10.1M	N/A	-$303K+88.9%	-$2.7M+47.6%	-$5.2M
Net Income	N/A	-$150.3M+82.7%	-$869.1M-3378.7%	-$25.0M	N/A	-$12.8M+60.0%	-$31.9M-45.8%	-$21.9M
EPS (Diluted)	N/A	$-1.94+82.8%	$-11.30-3431.3%	$-0.32	N/A	$-0.16+61.9%	$-0.42-44.8%	$-0.29

ACH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.5B-47.3%	$4.7B-8.6%	$5.1B-5.4%	$5.4B+52.3%	$3.5B+6.0%	$3.3B
Current Assets	$547.9M-72.9%	$2.0B-3.9%	$2.1B-8.4%	$2.3B-1.1%	$2.3B+8.7%	$2.1B
Cash & Equivalents	$282.0M+922.7%	$27.6M-88.7%	$243.0M+249.9%	$69.5M+24.7%	$55.7M-32.9%	$83.1M
Inventory	$74.4M+10.1%	$67.6M-93.9%	$1.1B-16.7%	$1.3B-10.9%	$1.5B+21.3%	$1.2B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.2B0.0%	$1.2B-25.1%	$1.6B+0.1%	$1.6B+319.5%	$390.2M-1.0%	$394.1M
Total Liabilities	$2.9B-28.4%	$4.1B-2.4%	$4.2B-6.1%	$4.4B+70.9%	$2.6B-1.0%	$2.6B
Current Liabilities	$947.1M-48.9%	$1.9B-2.1%	$1.9B+20.8%	$1.6B+16.6%	$1.3B-0.1%	$1.3B
Long-Term Debt	$1.8B+0.1%	$1.8B-4.9%	$1.9B-23.9%	$2.5B+162.0%	$947.5M-3.9%	$986.0M
Total Equity	-$461.0M-178.6%	$586.4M-38.0%	$945.3M-2.2%	$966.7M+3.0%	$938.5M+31.8%	$712.1M
Retained Earnings	-$1.1B-4075.7%	$27.2M-92.6%	$368.7M-10.1%	$410.0M+5.8%	$387.6M+132.1%	$167.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$2.5B-39.3%	$4.0B-2.8%	$4.2B-14.5%	$4.9B+4.3%	$4.7B-8.4%	$5.1B-4.2%	$5.3B+1.8%	$5.2B
Current Assets	$547.9M-74.3%	$2.1B-7.3%	$2.3B+4.2%	$2.2B+9.2%	$2.0B-4.5%	$2.1B-9.0%	$2.3B+4.1%	$2.2B
Cash & Equivalents	$282.0M+758.8%	$32.8M-14.2%	$38.3M-35.6%	$59.4M+115.6%	$27.6M-39.3%	$45.5M-81.3%	$243.7M-0.5%	$244.9M
Inventory	$74.4M+16.6%	$63.8M-7.8%	$69.2M-95.1%	$1.4B+1984.2%	$67.6M-94.6%	$1.2B+0.9%	$1.2B+7.6%	$1.1B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.2B0.0%	$1.2B0.0%	$1.2B-7.8%	$1.3B+8.5%	$1.2B-25.2%	$1.6B+0.5%	$1.6B0.0%	$1.6B
Total Liabilities	$2.9B-34.8%	$4.5B+0.7%	$4.4B+3.5%	$4.3B+5.3%	$4.1B-3.3%	$4.2B-5.3%	$4.4B+3.0%	$4.3B
Current Liabilities	$947.1M-61.6%	$2.5B-7.8%	$2.7B+36.4%	$2.0B+5.8%	$1.9B-4.2%	$1.9B-9.2%	$2.1B+10.2%	$1.9B
Long-Term Debt	$1.8B-1.9%	$1.8B+15.1%	$1.6B-16.0%	$1.9B+5.5%	$1.8B-2.4%	$1.8B-1.6%	$1.9B-3.8%	$1.9B
Total Equity	-$461.0M-7.3%	-$429.5M-52.8%	-$281.0M-149.2%	$571.0M-2.6%	$586.4M-34.5%	$895.7M+1.6%	$881.8M-3.7%	$916.0M
Retained Earnings	-$1.1B-5.6%	-$1.0B-17.2%	-$871.9M-85578.9%	$1.0M-96.2%	$27.2M-91.0%	$302.1M-4.1%	$314.9M-9.2%	$346.8M

ACH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$101.8M-163.0%	$161.5M-78.2%	$740.7M+127.9%	$325.0M+161.7%	$124.2M-63.4%	$339.2M
Capital Expenditures	$191.0M+12.1%	$170.3M-1.2%	$172.4M+9.0%	$158.1M+285.7%	$41.0M-18.7%	$50.4M
Free Cash Flow	-$292.7M-3230.1%	-$8.8M-101.5%	$568.3M+240.5%	$166.9M+100.6%	$83.2M-71.2%	$288.8M
Investing Cash Flow	$144.4M+223.9%	-$116.5M+15.1%	-$137.3M+92.4%	-$1.8B-3264.7%	-$53.6M-167.0%	$80.1M
Financing Cash Flow	$188.1M+170.3%	-$267.6M+35.9%	-$417.3M-127.9%	$1.5B+1256.3%	-$129.5M+65.9%	-$379.4M
Dividends Paid	N/A	N/A	$0	$0-100.0%	$731K+12.8%	$648K
Share Buybacks	$10.2M	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$68.2M+139.5%	-$172.5M-558.7%	$37.6M+207.3%	-$35.1M-149.4%	$71.0M+160.0%	$27.3M-76.5%	$116.1M+319.3%	-$53.0M
Capital Expenditures	$13.1M-75.8%	$54.2M	N/A	N/A	$22.3M-63.8%	$61.5M+34.3%	$45.8M-0.4%	$46.0M
Free Cash Flow	$55.1M+124.3%	-$226.8M	N/A	N/A	$48.7M+242.5%	-$34.2M-148.6%	$70.3M+171.1%	-$99.0M
Investing Cash Flow	$285.0M+822.2%	-$39.5M+25.4%	-$52.9M-9.8%	-$48.2M+7.8%	-$52.3M-92.4%	-$27.2M+22.7%	-$35.2M-1780.7%	-$1.9M
Financing Cash Flow	-$117.5M-164.9%	$181.1M+471.3%	$31.7M-65.8%	$92.8M+315.3%	-$43.1M+78.4%	-$199.6M-155.1%	-$78.2M-246.7%	$53.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$3.5M	$0-100.0%	$5.2M+242.8%	$1.5M	N/A	$0	$0	$0

ACH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	46.7%-36.1pp	82.8%-0.5pp	83.3%+64.9pp	18.4%+2.9pp	15.5%+0.4pp	15.1%
Operating Margin	1.0%+9.1pp	-8.1%-13.3pp	5.2%+3.8pp	1.4%-2.3pp	3.8%+1.4pp	2.4%
Net Margin	-39.9%-26.3pp	-13.5%-11.9pp	-1.6%-1.8pp	0.2%-2.0pp	2.3%+1.9pp	0.4%
Return on Equity	N/A	-61.9%-57.5pp	-4.4%-6.7pp	2.3%-21.3pp	23.6%+19.4pp	4.2%
Return on Assets	-44.9%-37.1pp	-7.8%-7.0pp	-0.8%-1.2pp	0.4%-5.9pp	6.3%+5.4pp	0.9%
Current Ratio	0.58-0.5	1.09-0.0	1.11-0.4	1.47-0.3	1.73+0.1	1.59
Debt-to-Equity	-3.90-7.0	3.07+1.1	2.00-0.6	2.57+1.6	1.01-0.4	1.38
FCF Margin	-10.6%-10.3pp	-0.3%-22.6pp	22.3%+20.6pp	1.7%+0.8pp	0.9%-2.6pp	3.4%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	46.2%-1.4pp	47.6%+27.6pp	20.0%	N/A	81.5%-0.9pp	82.4%+61.9pp	20.5%
Operating Margin	N/A	3.8%+9.6pp	-5.8%-5.8pp	0.0%	N/A	4.5%+2.0pp	2.6%+2.2pp	0.4%
Net Margin	N/A	-21.6%+105.9pp	-127.4%-126.5pp	-0.9%	N/A	-1.9%+3.0pp	-4.8%-4.0pp	-0.8%
Return on Equity	N/A	N/A	N/A	-4.4%	N/A	-1.4%+2.2pp	-3.6%-1.2pp	-2.4%
Return on Assets	N/A	-3.7%+17.2pp	-20.9%-20.4pp	-0.5%	N/A	-0.3%+0.4pp	-0.6%-0.2pp	-0.4%
Current Ratio	0.58-0.3	0.860.0	0.86-0.3	1.13+0.0	1.090.0	1.090.0	1.09-0.1	1.16
Debt-to-Equity	-3.90+0.4	-4.27+1.4	-5.67-9.0	3.32+0.3	3.07+1.0	2.06-0.1	2.120.0	2.12
FCF Margin	N/A	-32.5%	N/A	N/A	N/A	-5.0%-15.6pp	10.7%+14.4pp	-3.8%

Note: Shareholder equity is negative (-$461.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.58), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Accendra Health Inc's annual revenue?

Accendra Health Inc (ACH) reported $2.8B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Accendra Health Inc's revenue growing?

Accendra Health Inc (ACH) revenue grew by 3.1% year-over-year, from $2.7B to $2.8B in fiscal year 2025.

Is Accendra Health Inc profitable?

No, Accendra Health Inc (ACH) reported a net income of -$1.1B in fiscal year 2025, with a net profit margin of -39.9%.

What is Accendra Health Inc's EBITDA?

Accendra Health Inc (ACH) had EBITDA of $242.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Accendra Health Inc have?

As of fiscal year 2025, Accendra Health Inc (ACH) had $282.0M in cash and equivalents against $1.8B in long-term debt.

What is Accendra Health Inc's gross margin?

Accendra Health Inc (ACH) had a gross margin of 46.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Accendra Health Inc's operating margin?

Accendra Health Inc (ACH) had an operating margin of 1.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Accendra Health Inc's net profit margin?

Accendra Health Inc (ACH) had a net profit margin of -39.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Accendra Health Inc's free cash flow?

Accendra Health Inc (ACH) generated -$292.7M in free cash flow during fiscal year 2025. This represents a -3230.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Accendra Health Inc's operating cash flow?

Accendra Health Inc (ACH) generated -$101.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Accendra Health Inc's total assets?

Accendra Health Inc (ACH) had $2.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Accendra Health Inc's capital expenditures?

Accendra Health Inc (ACH) invested $191.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Accendra Health Inc buy back shares?

Yes, Accendra Health Inc (ACH) spent $10.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Accendra Health Inc have outstanding?

Accendra Health Inc (ACH) had 76M shares outstanding as of fiscal year 2025.

What is Accendra Health Inc's current ratio?

Accendra Health Inc (ACH) had a current ratio of 0.58 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Accendra Health Inc's debt-to-equity ratio?

Accendra Health Inc (ACH) had a debt-to-equity ratio of -3.90 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Accendra Health Inc's return on assets (ROA)?

Accendra Health Inc (ACH) had a return on assets of -44.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Accendra Health Inc's cash runway?

Based on fiscal year 2025 data, Accendra Health Inc (ACH) had $282.0M in cash against an annual operating cash burn of $101.8M. This gives an estimated cash runway of approximately 33 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Accendra Health Inc's debt-to-equity ratio negative or unusual?

Accendra Health Inc (ACH) has negative shareholder equity of -$461.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Accendra Health Inc's Altman Z-Score?

Accendra Health Inc (ACH) has an Altman Z-Score of 0.40, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Accendra Health Inc's Piotroski F-Score?

Accendra Health Inc (ACH) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Accendra Health Inc's earnings high quality?

Accendra Health Inc (ACH) has an earnings quality ratio of 0.09x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Accendra Health Inc cover its interest payments?

Accendra Health Inc (ACH) has an interest coverage ratio of 0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Accendra Health Inc?

Accendra Health Inc (ACH) scores 21 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.